Infectious Disease Alert – December 1, 2002
December 1, 2002
View Issues
-
Yellow Fever Vaccination
The current recommendations for yellow fever vaccination are summarized. -
Iron, Lactoferrin, and Biofilms
By sequestering iron, lactoferrin enhances twitching motility of P aeruginosa and, as a result, prevents biofilm formation. -
Urban Leishmaniasis
Leishmaniasis marches on in parallel with population migrations to urban areas in developing countries. -
TRAPped
Recurrent febrile episodes with localized myalgia and an erythematous, tender skin eruption overlying the painful muscle group are among the most common manifestation of the tumor necrosis factor receptor-associated periodic syndrome (TRAPS). -
Updates
Transfusion-Associated WNV; Patient Privacy Laws2002 -
Pharmacology Watch: FDA Approves Generic Version of AstraZeneca’s Prilosec
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By Sex; McClellan Named FDA Commissioner; FDA Actions -
Clinical Briefs in Primary Care Supplement
Vitamin-Mineral Supplementation and Acute RTI in Elderly; B-Type Natriuretic Peptide Levels and Outcome in Heart Failure; Companion Influence During Primary Care Encounters; Handrubbing with Alcohol-Based Solution vs. Standard Handwashing; Program To Prevent Functional Decline in Frail Elderly Who Live at Home; Treatment of Diabetic Neuropathy with Isosorbide Dinitrate Spray